The marketing authorisation holder informed its customers on April 4, 2019 that there is a risk that "Parkemed - Suspension zur oralen Anwendung" will likely contain levels of Lead (Pb) and Lithium (Li) which exceed the Permitted Daily Exposure (PDE) levels. Therefore all batches within shelf-life are recalled as a precautionary measure.
|Name of the medicinal product||Parkemed - Suspension zur oralen Anwendung|
|Marketing authorisation number(s)||13621|
|Marketing authorisation holder||Pfizer Corporation Austria GmbH|
|Batch number(s)||1609777, 1609778, 1703778, 1703724, 1706159, 1706160|
|Classification of the recall||2|
|Depth of recall||Pharmacies|
|BASG reference number||INS-640.001-2835|